Open Access

The importance of neutrophil-to-lymphocyte ratio before and after radiation in breast cancer patients

Behar Raci

Behar Raci

  • University Clinical Center of KosovoPrishtina, Kosovo
  • University Clinic for Infectious Diseases & Febrile Conditions, Faculty of MedicineSkopje, North Macedonia
Orcid profile
Search for this author on
Sciendo|Google Scholar
Raci, Behar
, 
Snezana Stojkovska

Snezana Stojkovska

University Clinic for Infectious Diseases & Febrile Conditions, Faculty of MedicineSkopje, North Macedonia
Orcid profile
Search for this author on
Sciendo|Google Scholar
Stojkovska, Snezana
, 
Meleq Bahtijari

Meleq Bahtijari

Faculty of Medicine, University of PrishtinaPrishtina, Kosovo
Orcid profile
Search for this author on
Sciendo|Google Scholar
Bahtijari, Meleq
, 
Gezim Hodolli

Gezim Hodolli

Faculty of Veterinary and Agriculture, University of PrishtinaPrishtina, Kosovo
Orcid profile
Search for this author on
Sciendo|Google Scholar
Hodolli, Gezim
, 
Gazmend Nafez

Gazmend Nafez

Faculty of Mathematican and Natural Scıence, University of PrishtinaPrishtina, Kosovo
Orcid profile
Search for this author on
Sciendo|Google Scholar
Nafez, Gazmend
, 
Burim Uka

Burim Uka

  • University Clinical Center of KosovoPrishtina, Kosovo
  • Faculty of Radiology, UBT Higher Education InstitutionPrishtina, Kosovo
Orcid profile
Search for this author on
Sciendo|Google Scholar
Uka, Burim
 and 
Diellor Rizaj

Diellor Rizaj

  • University Clinical Center of KosovoPrishtina, Kosovo
  • Faculty of Radiology, UBT Higher Education InstitutionPrishtina, Kosovo
Orcid profile
Search for this author on
Sciendo|Google Scholar
Rizaj, Diellor
  
Jul 12, 2025
The importance of neutrophil-to-lymphocyte ratio before and after radiation in breast cancer patients's Cover Image
About this article
Previous Article
Next Article
Cite
Download Cover
Article Category: Research Article
Published Online: Jul 12, 2025
Page range: 45 - 52
Received: Jun 15, 2024
Accepted: Oct 02, 2024
DOI: https://doi.org/10.2478/fco-2024-0009
Keywords
© 2024 Behar Raci et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Figure 1:

The overall survival of treated patients by years.
The overall survival of treated patients by years.

Figure 2:

Percentage of lymphocyte and neutrophil values before and after treatment.
Percentage of lymphocyte and neutrophil values before and after treatment.

NLR pre- and post-treatment for grouped by stades, gradus and treatment fractions_

Staging NLR
Pre-treatment Post-treatment
I 1.62 2.63
IA 1.95 2.48
II 1.92 4.11
IIA 2.93 3.39
IIB 1.58 2.67
III 2.10 1.36
IIIA 2.01 3.03
IIIB 1.56 1.80
IIIC 1.90 2.25

Descriptive Statistics – Patient Characteristics_

N = 56 %
Median age (years) 53.42 (32–75)
Sex
Female 56 100
Male 0 0
Age group
>40 51 91.07
≤40 5 8.93
Comorbidity
No 12 21.43
Diabetes 5 8.93
Hypertension 29 51.79
Diabetes + hypertension 10 17.86
Stage
I 2 3.57
IA 3 5.36
II 8 14.29
IIA 6 10.71
IIB 13 23.21
III 1 1.79
IIIA 15 26.79
IIIB 2 3.57
IIIC 6 10.71
Histopathologic type
Ductal carcinoma 31 55.36
Non-ductal carcinoma 25 44.64
Grade
Grade 1 4 7.14
Grade 2 30 53.57
Grade 3 22 39.29
Chemotherapy cycle
Four cycles 6 10.71
Six cycles 11 19.64
Eight cycle 39 69.64
Radiotherapy fractions
25 29 51.79
28 20 35.71
30 7 12.50
Language:
English
Publication timeframe:
2 times per year
Journal Subjects:
Medicine, Clinical Medicine, Internal Medicine, Haematology, Oncology
Journal RSS Feed